Globe Newswire
Festi hf. published its Q1 2024 results after market closing on 23 April 2024.
Please find attached the Q1 2024 investor presentation for investor meeting held today, Wednesday 24 April 2024 at 8:30.
Attachment
WisdomTree Issuer plc – Daily Fund Prices 23-April-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc23/04/2024IE00BDVPNG1314054630USD831,352,132.4759.1515WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged23/04/2024IE00BFNNN2361662036EUR136,143,772.1781.9139WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged23/04/2024IE00BFNNN459171509GBP14,708,246.0385.7579WisdomTree AT1 CoCo Bond UCITS ETF -... (continue reading...)
Prosafe SE will release its first quarter 2024 results on May 8, 2024, at approximately 07:00 a.m. CET. The Q1 2024 presentation will be published on www.newsweb.no and on Prosafe’s website www.prosafe.com.
Terje Askvig, CEO, and Reese McNeel, CFO, will, on the same day at 10:00 a.m. CET, present the results at Pareto Securities, Dronning Mauds gate 3, 0115 Oslo. The presentation is open to the public and can also be followed live via web streaming at ... (continue reading...)
Company Announcement No 31/2024
Breakdown of debtors, Realkredit Danmark A/S
Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes breakdown of debtors as of Friday 19 April 2024. Please find the data in the attached file.
The information will also be available on www.rd.dk.
Yours... (continue reading...)
- The preliminary results from the phase 2 study investigating AFM24 in combination with the checkpoint inhibitor atezolizumab in patients with EGFR wild-type non-small cell lung cancer have been accepted for poster presentation
MANNHEIM, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that an abstract presenting... (continue reading...)
More Globe Newswire
View Older Stories-
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
-
Perceptyx Launches Activate, HR’s Missing Link Between Employee Insight and Impact
-
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
-
New Induction Heating System Revolutionizes Metal Processing with Enhanced Efficiency and Stress Relief Capabilities
-
CGG: Availability of the preparatory documents for the Combined General Meeting
-
WOO X Lists $CKB on its Spot Market
-
Title correction: EXEL Industries : Second quarter 2023–2024 sales down 1.8%
-
CallTower's Seanna Baumgartner Recognized as an Icon's Edge Top 10 Inspiring Leaders of 2024
-
Consensus estimates ahead of Q1 2024
-
Tower Semiconductor Announces First Quarter 2024 Financial Results and Conference Call
-
Municipality Finance issues a GBP 25 million tap under its MTN programme
-
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair
-
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology
-
JuneX Capital Partners Launch “Founders Office“ with €100M Evergreen Fund to Back European Entrepreneurs in Human Capital and Investment Management
-
FORVIA TO OFFER AN ADDITIONAL €200 MILLION OF 5.500% SENIOR NOTES DUE 2031 AIMING TO PARTIALLY REFINANCE ITS 7.250% 2026 BONDS
-
Scatec signs PPA with Statkraft for new 142 MW solar plant in Brazil
-
Siili Solutions Plc: Business review, 1 January–31 March 2024
-
Enlight Research analysed INVL Technology’s financial results for 2023
-
Form 8.5 (EPT/RI) - Renalytix plc
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Futu Announces the Number of Its Clients in Malaysia Has Surpassed 100,000
-
News from INVL Technology managed companies: NRD Cyber Security's growth shows an increasing demand for quality cybersecurity services
-
Groupe Casino: The New Casino embarks on its transformation plan
-
Stolt-Nielsen Limited shares trade ex-dividend
-
Heineken Holding N.V. reports on 2024 first-quarter trading
-
Cornish Metals Launches New Interactive Investor Hub
-
AAVantgarde announces updated NHP data from its Stargardt disease program in a poster presentation at the ARVO 2024 annual meeting
-
NBPE Announces Audited 2023 Results and 31 March 2024 Est. NAV
-
Pharming Group to report first quarter 2024 financial results on May 8
-
Heineken N.V. reports on 2024 first-quarter trading
-
Transaction in own shares
-
Michelin : Disclosure of trading in own shares - April 24th 2024
-
EXEL Industries : Second quarter 2023–2024 sales: up 1.8%
-
Vistin Pharma ASA: First quarter 2024 financial results
-
DSV, 1104 - LAUNCH OF NEW SHARE BUYBACK PROGRAMME ACCORDING TO THE SAFE HARBOUR METHOD
-
DSV, 1103 - INTERIM FINANCIAL REPORT Q1 2024
-
Press Release Orange: Good start to the year, strong momentum on “Lead the Future”
-
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
-
Ringkjøbing Landbobank’s quarterly report for the first quarter of 2024
-
Transaction in Own Shares
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Q1 2024 results: KPN delivers solid start to the year
-
Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent
-
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
-
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
-
WithSecure Interim report 1 January – 31 March 2024: Elements Company profitability developing positively, despite slow start of the year
-
Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarter
-
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
